Vaccine News and Research

Latest Vaccine News and Research

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

In a recent study posted to the medRxiv* preprint server, researchers assessed variables that influence anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers in medical professionals.

16 May 2022

An atlas of human immune cells across tissues

In a recent article published in the Science journal, researchers demonstrated tissue-specific immune cell characteristics in humans by performing cross-tissue immune cell evaluation.

16 May 2022

Malaria eradication calls for detection and treatment of asymptomatic cases

Asymptomatic malaria infections do not reduce the risk of severe disease, as widely believed, but suppress the immune system and prevent it from getting rid of parasites that persist in the bloodstream, research suggests.

16 May 2022

Landmark $20 million gift received to establish Mount Sinai-Royalty Pharma Alliance for Health Equity Research

Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over four years from Royalty Pharma plc and certain members of its management team.

16 May 2022

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Researchers assessed the immune responses induced by two doses or three doses of the BNT162b2 (BNT) or the CoronaVac (CorV) vaccine against SARS-CoV-2 Omicron BA.2 sublineage among public servants working for the government of Hong Kong.

16 May 2022

Unique antibody responses after third COVID-19 mRNA vaccination

Researchers observed that a third messenger ribonucleic acid COVID-19 vaccine elicits a unique antibody response.

16 May 2022

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Researchers observed that the SARS-CoV-2 Omicron BA.2 variant is immunologically different from other variants, including Omicron BA.1.

16 May 2022

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Researchers compared the immunogenicity of or and reactogenicity to the BNT162b2 vaccine in Japanese adults and elders.

16 May 2022

Ocular toxoplasmosis found to be common among Australians

One in 150 Australians have retinal scars caused by the Toxoplasma parasite, according to new Flinders University analysis.

16 May 2022

Sentiment toward COVID-19 vaccines previews subsequent vaccination rates, Twitter study finds

Sentiments toward COVID-19 vaccines, whether positive or negative, previews subsequent vaccination rates, finds a study of related Twitter posts.

15 May 2022

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety, immunogenicity, and efficacy of the messenger ribonucleic acid (mRNA)-1273 vaccine in children.

13 May 2022

Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

A new study published in Open Forum Infectious Diseases has focused on analyzing the efficacy of COVID-19 vaccination against PASC, utilizing multicentre data across the USA.

13 May 2022

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Researchers created polystyrene sulfonate with significantly different molar masses, constructed these polymers as an exterior around spherical gold nanoparticles of various sizes to improve multivalency effects, measured antiviral effects of the antivirals on numerous viruses in vitro, and investigated the method of interaction of the leads with SARS-CoV-2 and lentiviral particles.

13 May 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Scientists have determined the effectiveness of different vaccination regimens in eliciting humoral immune responses against the SARS-CoV-2 Omicron variant.

13 May 2022

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

A new study has longitudinally traced and profiled the CD8+ T cell responses after COVID-19 mRNA booster vaccination.

13 May 2022

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

In a recent study posted to the bioRxiv* preprint server, researchers explored the role of the N-terminal domain (NTD) of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) spike (S) protein in SARS-CoV-2 fusion with the host membranes and coronavirus disease 2019 (COVID-19).

12 May 2022

New project aims to improve exercise adherence in hemodialysis patients

There are approximately 600,000 individuals in the U.S. who are undergoing hemodialysis (HD) therapy for kidney failure. In hemodialysis, a machine filters wastes, salts, and fluid from the blood when an individual's kidneys are no longer healthy enough to do this work adequately.

12 May 2022

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

In a recent study posted to the bioRxiv* preprint server, researchers characterized the development of multiple adenovirus-vectored and subunit recombinant protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates.

12 May 2022

T-cell responses after COVID-19 and vaccinations

A new study published in the journal Frontiers in immunology examines the cell-mediated immunity in BNT162b2 COVID-19 mRNA vaccinated health care workers and COVID-19 patients.

12 May 2022

Vaccine News and Research

Latest Vaccine News and Research

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

An atlas of human immune cells across tissues

Malaria eradication calls for detection and treatment of asymptomatic cases

Landmark $20 million gift received to establish Mount Sinai-Royalty Pharma Alliance for Health Equity Research

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Unique antibody responses after third COVID-19 mRNA vaccination

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Ocular toxoplasmosis found to be common among Australians

Sentiment toward COVID-19 vaccines previews subsequent vaccination rates, Twitter study finds

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

New project aims to improve exercise adherence in hemodialysis patients

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

T-cell responses after COVID-19 and vaccinations

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in